One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis

NCT06367361 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

336

Enrollment

OTHER

Sponsor class

Conditions

Fascioliasis

Interventions

DRUG: Oxfendazole
DRUG: Triclabendazole

Sponsor

Universidad Peruana Cayetano Heredia

Collaborators

[object Object]
[object Object]